In the α‐SMAhigh group, more than 40% of patients had poorly differentiated PDAC, in contrast to only 15% in the α‐SMAlow group, which highlights that high expression of α‐SMA is a marker of stronger tumor invasion and a worse prognosis. Here, ACTA1 is linked to neoplasm.